Intuitive Surgical (ISRG) experienced a 5.12% plummet during Friday's intraday trading session, underperforming the broader market as the company's slower procedure growth forecast for 2025 weighed on investor sentiment.
The medical technology company reported better-than-expected earnings and revenue for the fourth quarter, driven by strong sales of its da Vinci surgical robots. However, Intuitive Surgical's outlook for 2025 worldwide da Vinci procedure growth of 13% to 16% fell short of the 17% increase witnessed in the previous year, sparking concerns among investors.
Analysts noted that while the guidance was conservative, in line with Intuitive Surgical's typical approach, the slower projected growth rate compared to 2024 contributed to the stock's sell-off. Traders were skeptical about the company's ability to sustain its momentum, given the potential headwinds in certain market segments and the competitive landscape.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.